Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Oxytocin sale to be regulated in Punjab

      Oxytocin sale to be regulated in Punjab

      Medical Dialogues Bureau18 Sept 2018 9:36 AM IST
      Punjab: Aiming to put a check on misuse of Oxytocin, the State government has devised stringent measures to regulate Oxytocin sale in Punjab, informed...
      Alembic Pharma gets USFDA nod for depressive disorder drug

      Alembic Pharma gets USFDA nod for depressive disorder drug

      Medical Dialogues Bureau18 Sept 2018 9:32 AM IST
      Alembic Pharma has recently received approval from USFDA to market its product which is a generic equivalent of Wyeth Pharma Inc's Pristiq...
      Faulty hip implants: 15 patients seek relief from Health Ministry

      Faulty hip implants: 15 patients seek relief from Health Ministry

      Medical Dialogues Bureau18 Sept 2018 9:00 AM IST
      Union Health Ministry said the panel has so far received representations from 15 affected patients from Faulty hip implants across the country and it...
      Prescribing Nimesulide- Beware of these combinations

      Prescribing Nimesulide- Beware of these combinations

      Medical Dialogues Bureau17 Sept 2018 4:05 PM IST
      The central government has banned many Nimesulide combinations after the DTAB recommended, amongst other things, that there is no therapeutic...
      Manipal Hospitals ropes in Rahul Dravid as brand ambassador

      Manipal Hospitals ropes in Rahul Dravid as brand ambassador

      Medical Dialogues Bureau17 Sept 2018 3:50 PM IST
      Manipal Hospitals, one of India’s leading healthcare provider today announced Mr Rahul Dravid, former Indian Cricketer as the brand ambassador. New...
      Boehringer Ingelheim acquires ViraTherapeutics for 250 million dollars

      Boehringer Ingelheim acquires ViraTherapeutics for 250 million dollars

      Medical Dialogues Bureau17 Sept 2018 3:50 PM IST
      ViraTherapeutics was a portfolio company of the two venture investors EMBL Ventures and the Boehringer Ingelheim Venture Fund (BIVF)has a transaction...
      Glenmark Pharma receives USFDA approval for Estradiol Vaginal Insert

      Glenmark Pharma receives USFDA approval for Estradiol Vaginal Insert

      Medical Dialogues Bureau17 Sept 2018 10:22 AM IST
      Glenmark Pharma has received final approval from the US health regulator for the generic version of Nordisk Inc's VAGIFEM, used for providing relief...
      Sanofi pledges to keep up its restructuring efforts

      Sanofi pledges to keep up its restructuring efforts

      Medical Dialogues Bureau17 Sept 2018 9:15 AM IST
      PARIS: Sanofi will continue to implement cost savings after having reached a 1.5 billion euros ($1.75 billion) cost reduction target a year ahead of...
      Banned : Azithromycin and Ofloxacin combination

      Banned : Azithromycin and Ofloxacin combination

      Medical Dialogues Bureau16 Sept 2018 11:14 AM IST
      The central government prohibited drug combination of Azithromycin +ofloxacin noting that the said there is no therapeutic justification for the...
      Takeda gets China approval for Whooping 62 Billion Dollar Shire purchase

      Takeda gets China approval for Whooping 62 Billion Dollar Shire purchase

      Medical Dialogues Bureau16 Sept 2018 9:52 AM IST
      Takeda Pharmaceutical Co Ltd said that China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the...
      Regulators flag second impurity in Valsartan drug

      Regulators flag second impurity in Valsartan drug

      Medical Dialogues Bureau16 Sept 2018 9:08 AM IST
      Blood pressure drug valsartan, produced by China’s Zhejiang Huahai Pharmaceutical, was this year found to contain traces of N-nitrosodimethylamine...
      Roche steps up efficiency drive to take sting out of biosimilars

      Roche steps up efficiency drive to take sting out of biosimilars

      Medical Dialogues Bureau16 Sept 2018 9:05 AM IST
      LONDON/ZURICH: Roche, the world's biggest producer of cancer drugs, is stepping up cost cuts in an efficiency drive made unavoidable by competition...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok